|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | G01N 33/53 | |
| A61K 31/015 |
| (11) | Number of the document | 2478362 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10817999.5 |
| Date of filing the European patent application | 2010-09-20 | |
| (97) | Date of publication of the European application | 2012-07-25 |
| (45) | Date of publication and mention of the grant of the patent | 2016-05-11 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2010/049545 |
| Date | 2010-09-20 |
| (87) | Number | WO 2011/035274 |
| Date | 2011-03-24 |
| (30) | Number | Date | Country code |
| 276969 P | 2009-09-18 | US |
| (72) |
TRIEU, Vuong, US
DESAI, Neil, US
|
| (73) |
Abraxis BioScience, LLC,
11755 Wilshire Boulevard, Los Angeles, CA 90025,
US
|
| (54) | USE OF THE SPARC MICROENVIRONMENT SIGNATURE IN THE TREATMENT OF CANCER |
| USE OF THE SPARC MICROENVIRONMENT SIGNATURE IN THE TREATMENT OF CANCER |